Chlorpyrifos developmental neurotoxicity: Interaction with glucocorticoids in PC12 cells

Neurotoxicology and Teratology

Volumn 34, Issue 5, 2012, Pages 505-512

  Slotkin, Theodore A ^a   Card, Jennifer ^a   Seidler, Frederic J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Chlorpyrifos; Dexamethasone; Glucocorticoids; Organophosphate pesticides; PC12 cells; Preterm delivery

Indexed keywords

CHLORPYRIFOS; DEXAMETHASONE; GLUCOCORTICOID;

ARTICLE; CELL COUNT; CELL LOSS; CELL STRAIN; CELL SWELLING; CHOLINERGIC NERVE CELL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DEVELOPMENTAL TOXICITY; DOPAMINERGIC NERVE CELL; NERVE CELL DIFFERENTIATION; NEUROTOXICITY; PRIORITY JOURNAL;

ANIMALS; CELL CULTURE TECHNIQUES; CHLORPYRIFOS; DRUG INTERACTIONS; FEMALE; GLUCOCORTICOIDS; HUMANS; INSECTICIDES; MODELS, BIOLOGICAL; NEUROGENESIS; NEUROTOXICITY SYNDROMES; PC12 CELLS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS;

EID: 84864487311     PISSN: 08920362     EISSN: 18729738     Source Type: Journal    
DOI: 10.1016/j.ntt.2012.07.002     Document Type: Article

References (62)

1. Abraham I.M., Harkany T., Horvath K.M., Luiten P.G.M. Action of glucocorticoids on survival of nerve cells: promoting neurodegeneration or neuroprotection?. J Neuroendocrinol 2001, 13:749-760.
2. Ahlbom E., Gogvadze V., Chen M., Celsi G., Ceccatelli S. Prenatal exposure to high levels of glucocorticoids increases the susceptibility of cerebellar granule cells to oxidative stress-induced cell death. Proc Natl Acad Sci 2000, 97:14726-14730.
3. Aisa B., Gil-Bea F.J., Marcos B., Tordera R., Lasheras B., Del Rio J., et al. Neonatal stress affects vulnerability of cholinergic neurons and cognition in the rat: involvement of the HPA axis. Psychoneuroendocrinology 2009, 34:1495-1505.
4. Aldridge J.E., Meyer A., Seidler F.J., Slotkin T.A. Developmental exposure to terbutaline and chlorpyrifos: pharmacotherapy of preterm labor and an environmental neurotoxicant converge on serotonergic systems in neonatal rat brain regions. Toxicol Appl Pharmacol 2005, 203:134-144.
5. Bagchi D., Bagchi M., Hassoun E.A., Stohs S.J. In vitro and in vivo generation of reactive oxygen species, DNA damage and lactate dehydrogenase leakage by selected pesticides. Toxicology 1995, 104:129-140.
6. Bellinger D.C. A strategy for comparing the contributions of environmental chemicals and other risk factors to neurodevelopment of children. Environ Health Perspect 2012, 120:501-507.
7. Casida J.E., Quistad G.B. Organophosphate toxicology: safety aspects of nonacetylcholinesterase secondary targets. Chem Res Toxicol 2004, 17:983-998.
8. Cavalieri R.L., Cohen W.R. Antenatal steroid therapy: have we undervalued the risks?. J Matern Fetal Neonatal Med 2006, 19:265-269.
9. Charles B., Schild P., Steer P., Cartwright D., Donovan T. Pharmacokinetics of dexamethasone following single-dose intravenous administration to extremely low birth weight infants. Dev Pharmacol Ther 1993, 20:205-210.
10. Chumas P.D., Del Bigio M.R., Drake J.M., Tuor U.I. A comparison of the protective effect of dexamethasone to other potential prophylactic agents in a neonatal rat model of cerebral hypoxia-ischemia. J Neurosurg 1993, 79:414-420.
11. Colborn T. A case for revisiting the safety of pesticides: a closer look at neurodevelopment. Environ Health Perspect 2006, 114:10-17.
12. Colomina M.T., Albina M.L., Domingo J.L., Corbella J. Effects of maternal stress on methylmercury-induced developmental toxicity in mice. Physiol Behav 1995, 58:979-983.
13. Costa L.G. Neurotoxicity testing: a discussion of in vitro alternatives. Environ Health Perspect 1998, 106(Suppl. 2):505-510.
14. Costa L.G., Cole T.B., Furlong C.E. Polymorphisms of paraoxonase (PON1) and their significance in clinical toxicology of organophosphates. J Toxicol Clin Toxicol 2003, 41:37-45.
15. Crumpton T.L., Seidler F.J., Slotkin T.A. Is oxidative stress involved in the developmental neurotoxicity of chlorpyrifos?. Dev Brain Res 2000, 121:189-195.
16. Das K.P., Barone S. Neuronal differentiation in PC12 cells is inhibited by chlorpyrifos and its metabolites: is acetylcholinesterase inhibition the site of action?. Toxicol Appl Pharmacol 1999, 160:217-230.
17. Drake A.J., Tang J.I., Nyirenda M.J. Mechanisms underlying the role of glucocorticoids in the early life programming of adult disease. Clin Sci 2007, 113:219-232.
18. Ebert S.N., Lindley S.E., Bengoechea T.G., Bain D., Wong D.L. Adrenergic differentiation potential in PC12 cells: influence of sodium butyrate and dexamethasone. Mol Brain Res 1997, 47:24-30.
19. Fujita K., Lazarovici P., Guroff G. Regulation of the differentiation of PC12 pheochromocytoma cells. Environ Health Perspect 1989, 80:127-142.
20. Gilstrap L.C., Christensen R., Clewell W.H., D'Alton M.E., Davidson E.C., Escobedo M.B., et al. Effect of corticosteroids for fetal maturation on perinatal outcomes. J Am Med Assoc 1995, 273:413-418.
21. Gupta R.C. Brain regional heterogeneity and toxicological mechanisms of organophosphates and carbamates. Toxicol Mech Methods 2004, 14:103-143.
22. Hassan A.H.S., von Rosenstiel P., Patchev V.K., Holsboer F., Almeida O.F.X. Exacerbation of apoptosis in the dentate gyrus of the aged rat by dexamethasone and the protective role of corticosterone. Exp Neurol 1996, 140:43-52.
23. Howard A.S., Bucelli R., Jett D.A., Bruun D., Yang D.R. Chlorpyrifos exerts opposing effects on axonal and dendritic growth in primary neuronal cultures. Toxicol Appl Pharmacol 2005, 207:112-124.
24. Jameson R.R., Seidler F.J., Qiao D., Slotkin T.A. Chlorpyrifos affects phenotypic outcomes in a model of mammalian neurodevelopment: critical stages targeting differentiation in PC12 cells. Environ Health Perspect 2006, 114:667-672.
25. Jameson R.R., Seidler F.J., Qiao D., Slotkin T.A. Adverse neurodevelopmental effects of dexamethasone modeled in PC12 cells: identifying the critical stages and concentration thresholds for the targeting of cell acquisition, differentiation and viability. Neuropsychopharmacology 2006, 31:1647-1658.
26. Macaya A., Munell F., Ferrer I., DeTorres C., Reventos J. Cell death and associated c-jun induction in perinatal hypoxia-ischemia: effect of the neuroprotective drug dexamethasone. Mol Brain Res 1998, 56:29-37.
27. Matthews S.G., Owen D., Banjanin S., Andrews M.H. Glucocorticoids, hypothalamo-pituitary-adrenal (HPA) development, and life after birth. Endocr Res 2002, 28:709-718.
28. Meyer J.S. Biochemical effects of corticosteroids on neural tissues. Physiol Rev 1985, 65:946-1020.
29. Meyer A., Seidler F.J., Aldridge J.E., Slotkin T.A. Developmental exposure to terbutaline alters cell signaling in mature rat brain regions and augments the effects of subsequent neonatal exposure to the organophosphorus insecticide, chlorpyrifos. Toxicol Appl Pharmacol 2005, 203:154-166.
30. Moritz K.M., Boon W.M., Wintour E.M. Glucocorticoid programming of adult disease. Cell Tissue Res 2005, 322:81-88.
31. Mulholland P.J., Stepanyan T.D., Self R.L., Hensley A.K., Harris B.R., Kowalski A., et al. Corticosterone and dexamethasone potentiate cytotoxicity associated with oxygen-glucose deprivation in organotypic cerebellar slice cultures. Neuroscience 2005, 136:259-267.
32. Osathanondh R., Tulchinsky D., Kamali H., Fencl M., Taeusch H.W. Dexamethasone levels in treated pregnant women and newborn infants. J Pediatr 1977, 90:617-620.
33. Ostrea E.M., Morales V., Ngoumgna E., Prescilla R., Tan E., Hernandez E., et al. Prevalence of fetal exposure to environmental toxins as determined by meconium analysis. Neurotoxicology 2002, 23:329-339.
34. Povey A.C. Gene-environmental interactions and organophosphate toxicity. Toxicology 2010, 278:294-304.
35. Powers C.M., Wrench N., Ryde I.T., Smith A.M., Seidler F.J., Slotkin T.A. Silver impairs neurodevelopment: studies in PC12 cells. Environ Health Perspect 2010, 118:73-79.
36. Pryce C.R., Aubert Y., Maier C., Pearce P.C., Fuchs E. The developmental impact of prenatal stress, prenatal dexamethasone and postnatal social stress on physiology, behaviour and neuroanatomy of primate offspring: studies in rhesus macaque and common marmoset. Psychopharmacology 2011, 214:33-53.
37. Pung T., Klein B., Blodgett D., Jortner B., Ehrich M. Examination of concurrent exposure to repeated stress and chlorpyrifos on cholinergic, glutamatergic, and monoamine neurotransmitter systems in rat forebrain regions. Int J Toxicol 2006, 25:65-80.
38. Qiao D., Seidler F.J., Slotkin T.A. Developmental neurotoxicity of chlorpyrifos modeled in vitro: comparative effects of metabolites and other cholinesterase inhibitors on DNA synthesis in PC12 and C6 cells. Environ Health Perspect 2001, 109:909-913.
39. Qiao D., Seidler F.J., Violin J.D., Slotkin T.A. Nicotine is a developmental neurotoxicant and neuroprotectant: stage-selective inhibition of DNA synthesis coincident with shielding from effects of chlorpyrifos. Dev Brain Res 2003, 147:183-190.
40. Qiao D., Seidler F.J., Slotkin T.A. Oxidative mechanisms contributing to the developmental neurotoxicity of nicotine and chlorpyrifos. Toxicol Appl Pharmacol 2005, 206:17-26.
41. Radio N.M., Breier J.M., Shafer T.J., Mundy W.R. Assessment of chemical effects on neurite outgrowth in PC12 cells using high content screening. Toxicol Sci 2008, 105:106-118.
42. Rauh V., Arunajadai S., Horton M., Perera F., Hoepner L., Barr D.B., et al. 7-Year neurodevelopmental scores and prenatal exposure to chlorpyrifos, a common agricultural pesticide. Environ Health Perspect 2011, 10.1289/ehp.1003160.
43. Rauh V.A., Perera F.P., Horton M.K., Whyatt R.M., Bansal R., Hao X., et al. Brain abnormalities in children exposed to a common organophosphate pesticide. Proc Natl Acad Sci 2012, 109:7871-7876.
44. Rhodes M.C., Seidler F.J., Qiao D., Tate C.A., Cousins M.M., Slotkin T.A. Does pharmacotherapy for preterm labor sensitize the developing brain to environmental neurotoxicants? Cellular and synaptic effects of sequential exposure to terbutaline and chlorpyrifos in neonatal rats. Toxicol Appl Pharmacol 2004, 195:203-217.
45. Rokyta R., Yamamotova A., Slamberova R., Franek M., Vaculin S., Hruba L., et al. Prenatal and perinatal factors influencing nociception, addiction and behavior during ontogenetic development. Physiol Res 2008, 57(Suppl. 3):S79-S88.
46. Rosas L.G., Eskenazi B. Pesticides and child neurodevelopment. Curr Opin Pediatr 2008, 20:191-197.
47. Roy T.S., Sharma V., Seidler F.J., Slotkin T.A. Quantitative morphological assessment reveals neuronal and glial deficits in hippocampus after a brief subtoxic exposure to chlorpyrifos in neonatal rats. Dev Brain Res 2005, 155:71-80.
48. Rush T., Liu X.Q., Hjelmhaug J., Lobner D. Mechanisms of chlorpyrifos and diazinon induced neurotoxicity in cortical culture. Neuroscience 2010, 166:899-906.
49. Sachana M., Flaskos J., Sidiropoulou E., Yavari C.A., Hargreaves A.J. Inhibition of extension outgrowth in differentiating rat C6 glioma cells by chlorpyrifos and chlorpyrifos oxon: effects on microtubule proteins. Toxicol in Vitro 2008, 22:1387-1391.
50. Shaikh J., Karanth S., Chakraborty D., Pruett S., Pope C.N. Effects of daily stress or repeated paraoxon exposures on subacute pyridostigmine toxicity in rats. Arch Toxicol 2003, 77:576-583.
51. Slotkin T.A. Developmental cholinotoxicants: nicotine and chlorpyrifos. Environ Health Perspect 1999, 107(Suppl. 1):71-80.
52. Slotkin T.A. Cholinergic systems in brain development and disruption by neurotoxicants: nicotine, environmental tobacco smoke, organophosphates. Toxicol Appl Pharmacol 2004, 198:132-151.
53. Slotkin T.A. Developmental neurotoxicity of organophosphates: a case study of chlorpyrifos. Toxicity of organophosphate and carbamate pesticides 2005, 293-314. Elsevier Academic Press, San Diego. R.C. Gupta (Ed.).
54. Slotkin T.A., Seidler F.J. Developmental exposure to terbutaline and chlorpyrifos, separately or sequentially, elicits presynaptic serotonergic hyperactivity in juvenile and adolescent rats. Brain Res Bull 2007, 73:301-309.
55. Slotkin T.A., Seidler F.J. Developmental neurotoxicity of organophosphates targets cell cycle and apoptosis, revealed by transcriptional profiles in vivo and in vitro. Neurotoxicol Teratol 2012, 34:232-241.
56. Slotkin T.A., MacKillop E.A., Ryde I.T., Tate C.A., Seidler F.J. Screening for developmental neurotoxicity using PC12 cells: comparisons of organophosphates with a carbamate, an organochlorine and divalent nickel. Environ Health Perspect 2007, 115:93-101.
57. Song X., Violin J.D., Seidler F.J., Slotkin T.A. Modeling the developmental neurotoxicity of chlorpyrifos in vitro: macromolecule synthesis in PC12 cells. Toxicol Appl Pharmacol 1998, 151:182-191.
58. Tan D.H., Peng S.Q., Wu Y.L., Wang Y.M., Lu C.F., Ding W., et al. Chlorpyrifos induces delayed cytotoxicity after withdrawal in primary hippocampal neurons through extracellular signal-regulated kinase inhibition. Biol Pharm Bull 2009, 32:1649-1655.
59. Tegethoff M., Pryce C.R., Meinlschmidt G. Effects of intrauterine exposure to synthetic glucocorticoids on fetal, newborn, and infant hypothalamic-pituitary-adrenal axis function in humans: a systematic review. Endocr Rev 2009, 30:753-789.
60. Teng K.K., Greene L.A. Cultured PC12 cells: a model for neuronal function and differentiation. Cell biology: a laboratory handbook 1994, 218-224. Academic Press, San Diego. J.E. Celis (Ed.).
61. U.S.Food and Drug Administration FDA drug safety communication: new warnings against use of terbutaline to treat preterm labor [accessed 18 May 2012]. http://www.fda.gov/drugs/drugsafety/ucm243539.htm.
62. Winick M., Noble A. Quantitative changes in DNA, RNA and protein during prenatal and postnatal growth in the rat. Dev Biol 1965, 12:451-466.